Dados B3 › QUSW3 × VIVT3 · Português
Each row uses the most recent year in which BOTH companies have the figure, and says which year that is. A cell with ! carries a caveat — hover to read it. We do not name a winner: that would be a recommendation, and this site does not give any.
| indicator | QUSW3 | VIVT3 | year |
|---|---|---|---|
| ROE | 22.7%! | 8.9% | 2025 |
| ROIC | 24.3%! | 10.1% | 2025 |
| ROA | 9.1%! | 4.9% | 2025 |
| Gross margin | 100.0%! | 44.8% | 2025 |
| EBIT margin | 60.7%! | 16.5% | 2025 |
| Net margin | 39.2%! | 10.4% | 2025 |
| Net debt/EBITDA | 1.28x! | 0.53x | 2025 |
| Current ratio | 1.03x! | 1.00x | 2025 |
| Revenue growth (1y) | -3.1%! | 6.7% | 2025 |
| Revenue growth (5y CAGR) | -12.7%! | 6.7% | 2025 |
| Piotroski F-Score | 4/9! | 7/9 | 2025 |
Priced at the first session on or after the day each filing became public — never the period close.
| indicator | QUSW3 | VIVT3 | year |
|---|---|---|---|
| P/E | — | 21.78x | None × 2025 |
| P/B | — | 1.95x | None × 2025 |
| EV/EBITDA | — | 5.95x | None × 2025 |
| FCF yield | — | 8.4% | None × 2025 |
Numbers on this page are live. Data version 2026-09-01-supressao-declarada · page generated 2026-09-08 14:49 UTC. If this does not match /saude, you are reading a cached copy.
Home · Methodology · Transparency · Audit it